W.R. Berkley Corporation WRB is slated to report second-quarter 2024 earnings on Jul 22, before market open. The insurer delivered an earnings surprise in each of the last four reported quarters, the average beat being 9.81%. Factors to Consider Gross premiums written at the Insurance segment are likely to have benefited from well-performing other liability, short-tail lines and commercial auto. We expect the metric to be $3.2 billion. Increases in monoline excess and property reinsurance are likely to have aided the Reinsurance & Monoline Excess segment’s gross premiums written. We expect the metric to be $357.9 million. The Zacks Consensus Estimate for second-quarter 2024 premiums earned is pegged at $2.8 billion, indicating an increase of 10.8% from the year-ago reported quarter. Our estimate for the metric is also $2.8 billion. Higher interest rates, larger fixed maturity securities portfolio and Argentine inflation-linked securities, and reduction in investment expenses are likely to have aided net investment income. The upside is likely to be partially offset by decreases in income from investment funds, real estate and equity securities. The Zacks Consensus Estimate for second-quarter 2024 net investment income is pegged at $331 million, indicating an upside of 35% from the year-ago reported figure. We estimate the metric to be $340.2 million. Improvement in premiums, coupled with higher investment income, is likely to have aided revenues in the to-be-reported quarter. The Zacks Consensus Estimate is pegged at $3.3 billion, indicating an upside of 12.3% from the year-ago reported figure. Expenses are expected to have increased, owing to higher investment in technology and data and analytics as well as new startup operating unit expenses. We expect total expenses to increase 9.5% to $2.7 billion. W.R. Berkley is expected to have benefited from better pricing and increased exposure, coupled with prudent underwriting, which are likely to have aided underwriting profitability. The Zacks Consensus Estimate is currently pegged at 91. We estimate the combined ratio to be 90.3. Continued share buybacks are likely to have provided additional support to the bottom line. The Zacks Consensus Estimate for earnings per share is pegged at 82 cents, indicating a 7.89% increase from the year-ago quarter’s reported number. What the Zacks Model Unveils Our proven model does not conclusively predict an earnings beat for W.R. Berkley this time around. This is because the stock needs to have the right combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) for an earnings beat. This is not the case, as you can see here. Earnings ESP: W.R. Berkley has an Earnings ESP of -2.60% at present. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter. W.R. Berkley Corporation Price and EPS Surprise W.R. Berkley Corporation Price and EPS Surprise W.R. Berkley Corporation price-eps-surprise | W.R. Berkley Corporation Quote Zacks Rank: W.R. Berkley carries a Zacks Rank of 3 at present. Stocks to Consider Here are three P&C insurance stocks you may want to consider, as our model shows that these have the right combination of elements to post an earnings beat: Arch Capital Group ACGL has an Earnings ESP of +0.54% and a Zacks Rank #3 at present. The Zacks Consensus Estimate for second-quarter 2024 earnings is pegged at $2.16, indicating a year-over-year increase of 12.5%. You can see the complete list of today’s Zacks #1 Rank stocks here. ACGL’s earnings beat estimates in each of the last four reported quarters. First American Financial FAF has an Earnings ESP of +8.46% and a Zacks Rank #3 at present. The Zacks Consensus Estimate for second-quarter 2024 earnings is pegged at $1.13, indicating a year-over-year decrease of 16.3%. FAF earnings beat estimates in two of the last four reported quarters and missed twice. Fidelity National Financial, Inc. FNF has an Earnings ESP of +1.61% and a Zacks Rank #3 at present. The Zacks Consensus Estimate for second-quarter 2024 earnings is pegged at $1.27, indicating a year-over-year increase of 25.7%. FNF’s earnings beat estimates in one of the last four reported quarters and missed in the other three. Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report W.R. Berkley Corporation (WRB):Free Stock Analysis Report First American Financial Corporation (FAF):Free Stock Analysis Report Fidelity National Financial, Inc. (FNF):Free Stock Analysis Report Arch Capital Group Ltd. (ACGL):Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research
W.R. Berkley (WRB) to Report Q2 Earnings: What's in Store?
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...